脑脊液蛋白

  • 网络cerebrospinal fluid protein
脑脊液蛋白脑脊液蛋白
  1. 研究结果:1、本研究建立了人脑脊液蛋白组学技术体系。

    This study establish the proteomic technique system of cerebrospinal fluid . 2 .

  2. 目的在全自动分析仪上建立一种快速简便的脑脊液蛋白双缩脲测定法。

    Objective To establish a kind of rapid and simple biuret method for measuring cerebrospinal fluid protein of automatic analyser .

  3. 脑脊液蛋白及IgG轻度升高;

    The protein and IgG in cerebrospinal fluid elevated slightly .

  4. 实验室检查示:脑脊液蛋白水平和IgG指数增高最常见。

    Laboratory examinations : Protein and IgG-index levels in CSF were markedly high .

  5. 结果:治疗组在改善临床症状、促使脑脊液蛋白恢复正常和缩小颅内低密度灶等方面皆优于对照组(P0.05)。

    Results : The improvement of symptoms , recovery of cerebrospinal protein and reducing encephalic low density focus in the treatment group were significantly superior to that in the control group ( P0.05 ) .

  6. 脑脊液蛋白聚丙烯酰胺凝胶等电聚焦电泳

    Polyacrylamide Gel Isoelectric Focusing and Electrophoresis for CSF Proteins

  7. 感觉减退或消失、感觉性共济失调。4.脑脊液蛋白细胞分离。

    Hypoesthesia , anesthesia and sensory ataxia 4 . albuminocytologic dissociation in CSF .

  8. 本组病人表现慢性、复发性病程。全部病人均有弛缓性肢瘫,脑脊液蛋白细胞分离。

    Flaccid paralysis of extremities and elevated CSF protein were observed in all patients .

  9. 邻苯三酚红法定量测定尿蛋白用邻苯三酚红钼络合法测定尿液及脑脊液蛋白

    Pyrogallol red-molybdate complex method for the determination of total protein in urine and cerebrospinal fluid

  10. 非小细胞肺癌脑转移脑脊液蛋白质谱诊断模型的建立及其应用

    Establishment of diagnostic model of cerebrospinal protein fingerprint pattern for brain metastases from non-small cell lung cancer and its clinical application

  11. 脑膜瘤和脑良性肿瘤及脑外伤患者脑脊液蛋白质谱差异表达模型的研究

    SELDI-TOF analysis of cerebrospinal protein profiling to build the peptide patterns for distinguishing meningiomas from brain traumas and other benign brain tumors

  12. 脑脊液蛋白含量增高者148/150例,奎根试验示完全或部分梗阻者109例。

    The total protein content of CSF were increased in 148 / 150 cases and the Queckenstedt 's test showed total or partial block in 109 cases .

  13. 结论腹腔炎症病史、术前脑脊液蛋白及细胞数、手术方式、术中有无反复穿刺脑室是V-Ps术后分流管堵塞的高危因素。

    Conclusion celiac inflammation history , preoperative cerebrospinal fluid protein and cell number , operation mode , whether puncture ventricle repeatedly in surgery are the high-risk factors of shunt pipe plugging after V-Ps.

  14. 治疗组脑脊液蛋白、压力、糖、氯化物、细胞数恢复正常时间均较对照组明显缩短(P<0.01)。

    The recovery time of CSF pressure was shorter in the treatment group than in the control group , as well as that of the levels of protein , glucose , chlorides and cells ( P < 0.01 ) .

  15. 目的评价脑脊液14-3-3蛋白与多发性硬化(MS)患者轴索损害之间的关系。

    Objective To investigate the relationship between 14-3-3 protein in the cerebrospinal fluid ( CSF ) and the axonal damage of multiple sclerosis .

  16. 脑脊液tau蛋白含量测定对阿尔茨海默病的诊断价值

    Diagnostic value of tau in cerebrospinal fluid in Alzheimer disease

  17. 老年期痴呆患者脑脊液tau蛋白的检测及临床研究

    Detection of CSF tau levels of patients with senile dementia and clinical study

  18. 正常人群脑脊液Tau蛋白含量的定量分析

    Quantitative analysis of the Tau protein in cerebrospinal fluid in the healthy population

  19. 55例多梗死性痴呆患者脑脊液S-100蛋白的测定

    Measurement of S-100 Protein in Cerebrospinal Fluid of 55 Patients with Multi-infarct Dementia

  20. 老年痴呆患者脑脊液tau蛋白及Fas抗原变化的意义

    A study of changes of tau protein and Fas antigen in cerebrospinal fluid of elderly patients with dementia

  21. 结论免疫印迹法分析脑脊液14-3-3蛋白对判断MS患者急性期是否出现轴索损害及遗留神经功能缺损有一定的参考价值。

    Conclusion Immuno-blot of analysis of 14-3-3 protein in CSF is valuable in assessing axonal damage of multiple sclerosis and could be a useful biomarker to predict neurological impairment .

  22. 结论作为一项生物学指标,测定SD病人脑脊液tau蛋白的浓度有助于早期诊断AD和VD。

    Conclusion As a biological marker , the measurement of CSF tau levels in senile dementia ( SD ) patients is a useful tool in diagnosis of AD in the early stage .

  23. 统计方法采用采用重复测量的方差分析,分析脑脊液tau蛋白的水平与颅脑损伤严重程度及预后的关系。

    Repeated measures analysis of variance was utilized . The relationship between the CSF levels of tau protein and the severity and prognosis of head injury was analyzed .

  24. 目的探讨脑脊液tau蛋白浓度对老年期痴呆(SD),主要包括Alzheimers病(AD)和血管性痴呆(VD)的诊断价值。

    Objective To study the tau value of cerebrospinal fluid ( CSF ) and its significance in diagnosis of dementia including Alzheimer ′ s disease ( AD ) and cerebrovascular dementia ( VD ) .

  25. GBS患者脑脊液S100b蛋白含量随脑脊液单核细胞比例增减及病情的轻重而发生相应的变化。结论脑脊液和血清S100b蛋白含量与GBS患者病情严重程度相关。

    Conclusions CSF and blood serum S-100 beta protein level in patients with GBS may be related to the severity of the disease .

  26. 轻度认知功能障碍老年人和痴呆患者在脑脊液Tau蛋白、Aβ、Aβ前体蛋白、胆碱乙酰转移酶活性和事件相关电位等方面有类似变化。

    There are similar biological changes in older patients with MCI and Alzheimer 's disease , including Tau protein , beta-amyloid protein , amyloid precursor protein , choline acetyltransferase activity and event-related potentials .

  27. 结果急性脑梗死(ACI)患者血液和脑脊液S100b蛋白显著高于恢复期患者和对照组(P<0.01);

    Results Patients with acute cerebral infarction has a higher concentration of S - 100b protein of serum and cerebrospinal fluid than in control group ( P < 0 . 01 ) .

  28. 轻度、中度及重度异常脑电图患者脑脊液S100b蛋白浓度均高于血液(P<0.01);

    Concentration of S-100b protein of cerebrospinal fluid is significantly higher than that of blood in patients with light , midrange and weight anomaly electroencephalogram ( P < 0.01 ) .

  29. 结论利用原核细胞表达的GST1433蛋白可有效地诱导免疫动物产生特异性抗体,所制备的抗体可用于CJD病人脑脊液1433蛋白的检测。

    Conclusion Using purified prokaryotic expressed GST 14 3 3 fusion protein as antigen , the specific antibody was elicited in the immunized animals . The prepared antibody can be used in identification of 14 3 3 protein in CSF for the diagnosis of CJD .

  30. 本文对照组30例脑脊液铁蛋白含量为4.27±2.34ng/ml,提出以>9ng/ml为异常增高的指标。

    That the content of ferritin in the cerebrospinal fluid ( CSF ) is 4.27 ± 2.34ng/ml was determined in 30 cases of the compare group . The authors pro-pose that the abnormal increase rate is > 9ng / ml.